A new stent design may put patients at risk

Some stents that keep blood vessels open to treat heart disease are poorly designed to resist shortening, according to publications in the Journal of Interventional Cardiology. A case report published in the journal by Dr. Cindy Grines, of the Detroit Medical Center Cardiovascular Institute, and her colleagues describes a patient who experienced a heart attack after the recently marketed Ion stent (Boston Scientific, Natick, MA) in his artery shortened and accordioned. The articles indicate that some stents are susceptible to becoming deformed, which could result in adverse clinical consequences.

Coronary stents, which are scaffolds placed within arteries that to the heart, are lifesavers for many patients with heart disease and other conditions. By using and developing advanced designs, manufacturers have been working to continually improve the performance of stents to prevent blood vessels from becoming blocked.

Recently, though, researchers and clinicians have identified stent shortening as a newly observed deformity in cases using a particular family of stents. This shortening usually occurred when the clinician attempted to complete the procedure with the typical and balloons used after a stent is implanted. Stent shortening and deformity can cause serious complications for patients; in this case the stent clotted off and the patient had a .

In an accompanying editorial, Dr. Grines notes that the results are "disturbing" and that because clinicians, researchers, and regulators are rapidly investigating the issue, hopefully there will soon be new recommendations regarding the use of this particular design of stents.

add to favorites email to friend print save as pdf

Related Stories

Boston Scientific admits stent risks

Sep 07, 2006

The U.S.-based Boston Scientific Corp. has admitted there is an increased risk of blood clots caused by use of its drug-coated cardiac stent.

Drug-coated stents less risky for heart bypass patients

Jan 22, 2009

Coronary bypass surgery may carry less risk of serious complications if stents coated with a drug that suppresses cell growth are used in the procedure rather than bare-metal stents, UT Southwestern Medical Center researchers ...

Recommended for you

NT-proBNP modestly improves CVD risk prediction in women

Oct 24, 2014

(HealthDay)—N-terminal pro-B-type natriuretic peptide (NT-proBNP) modestly improves cardiovascular disease (CVD) risk prediction for women, according to a study published in the Oct. 28 issue of the Journal of ...

User comments